Browse drugs

… both tumors and stromal cells make them attractive targets for immunotherapeutic agents in cancer. The RGD (Arg-Gly-Asp)-binding integrin, αvβ6, is a c…

…vant therapy for oxaliplatin in colon cancer or the duration of trastuzumab in breast cancer, FDA labels are not regularly updated,25 and t…